Diagnostics

Amarantus BioScience Holdings, Inc. has acquired rights to two diagnostic platforms for the diagnosis of neurodegenerative diseases and oncology:

1. NuroPro^® Diagnostic Blood Test Platform
2. LymPro Alzheimer's Disease Diagnostic Blood Test